SpaceX recently completed a record IPO.

Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43. We rate LLY a buy with a 90% confidence score.

Johnson & Johnson doesn't need GLP-1 drugs to grow, and that's good news for long-term investors.

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact ...

Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market. Its revenues have become increasingly ...

Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.

The Pentagon just earmarked over $74 billion for drone dominance and counter drone technologies in the FY2027 budget request, and that is only one slice of the AI arms race AMD and NVIDIA are fighting ...

Eli Lilly transfers sole China rights for its cancer drug to a local partner, and the timing points to a looming problem ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

Shares of Eli Lilly LLY rose more than 7% on Friday after the company announced several positive developments related to its ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...